Cost-effectiveness Analysis in R Using a Multi-state Modeling Survival Analysis Framework: A Tutorial
暂无分享,去创建一个
Claire Williams | James D. Lewsey | Andrew H. Briggs | Daniel F. Mackay | J. Lewsey | A. Briggs | D. Mackay | Claire Williams
[1] Thomas Faunce,et al. Decision-analytical modelling in health-care economic evaluations , 2008, The European Journal of Health Economics.
[2] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[3] H Putter,et al. Tutorial in biostatistics: competing risks and multi‐state models , 2007, Statistics in medicine.
[4] J R Beck,et al. Markov Models in Medical Decision Making , 1993, Medical decision making : an international journal of the Society for Medical Decision Making.
[5] A. Berrebi,et al. Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial , 2010, The Lancet.
[6] Hein Putter,et al. mstate: An R Package for the Analysis of Competing Risks and Multi-State Models , 2011 .
[7] H. Akaike. A new look at the statistical model identification , 1974 .
[8] Andrew Briggs,et al. An Introduction to Markov Modelling for Economic Evaluation , 1998, PharmacoEconomics.
[9] A. Dhar,et al. National Institute for Health and Clinical Excellence , 2005 .
[10] Nicholas R Latimer,et al. Survival Analysis for Economic Evaluations Alongside Clinical Trials—Extrapolation with Patient-Level Data , 2013, Medical decision making : an international journal of the Society for Medical Decision Making.
[11] Jan A M Raaijmakers,et al. Development of a Framework for Cohort Simulation in Cost-Effectiveness Analyses Using a Multistep Ordinary Differential Equation Solver Algorithm in R , 2013, Medical decision making : an international journal of the Society for Medical Decision Making.
[12] Richard Grieve,et al. Extrapolation of Survival Data in Cost-effectiveness Analyses , 2013, Medical decision making : an international journal of the Society for Medical Decision Making.
[13] S. Wilson. Methods for the economic evaluation of health care programmes , 1987 .
[14] Mark Sculpher,et al. Cost-Effectiveness Analysis of Treatments for Chronic Disease: Using R to Incorporate Time Dependency of Treatment Response , 2005, Medical decision making : an international journal of the Society for Medical Decision Making.
[15] Sarah Hancock,et al. FLUDARABINE AS FIRST LINE THERAPY FOR CHRONIC LYMPHOCYTIC LEUKAEMIA , 2003 .
[16] Nicky J Welton,et al. Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves , 2012, BMC Medical Research Methodology.
[17] Hein Putter,et al. The mstate package for estimation and prediction in non- and semi-parametric multi-state and competing risks models , 2010, Comput. Methods Programs Biomed..
[18] M. Connock,et al. Cautions Regarding the Fitting and Interpretation of Survival Curves , 2011, PharmacoEconomics.
[19] Elisabeth Fenwick,et al. Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation , 2006, BMC Health Services Research.